A study found that long-term health-related quality of life is high among survivors of out-of-hospital cardiac arrest. Duke Han, PhD, and Laura Fenton, a doctoral student, describe a study that shows the impact of cognitive impairment. Following new protocols allows for many lung cancer patients to leave the hospital 1 day after surgery. The combination of durvalumab plus concurrent radiotherapy shows promising in treating NSCLC. Dr. Fahar Merchant, president and CEO of Medicenna, talks about a promising therapy for combating recurrent glioblastoma. Three patient case reports showed that osimertinib is a promising and viable treatment option for lung cancer with bone mets. A study assessed the link between osimertinib and VEGF expression in patients with advanced non-small cell lung cancer. Osimertinib treatment was safe and effective in patients with advanced small-cell lung cancer treated amid the pandemic. The combination of pembrolizumab and lenvatinib did not improve survival in metastatic CRC. The FRESCO-2 study showed that fruquintinib resulted in an overall survival benefit in metastatic colorectal cancer. Dr. Ross Campbell discusses the OPERA-AI study results and how AI can be used to diagnose heart failure.
Dr. Eng discusses the phase 3 FRESCO-2 study and how fruquintinib fits in with current treatments for advanced CRC. Findings from a recent study suggest that racial disparities exist in the presentation of frontotemporal dementia. The U.S. FDA has accepted a Biologics License Application for a novel drug to treat paroxysmal nocturnal hemoglobinuria. Atrial fibrillation ablation is linked to lower rates of mortality and a decreased need for LVAD compared with therapy. The rate of colorectal cancer (CRC) screenings decreased by more than 20% during the COVID-19 pandemic. Results from a recent study suggest a novel therapy that may effectively treat pancreatic ductal adenocarcinoma. Narcan, a drug used to reverse opioid overdose, will be available over the counter in retail stores as soon as next week. Kimberly Brownell, CCC-SLP, talks about the importance of speech and language pathologists. The Biden administration unveiled a list of 10 medications that will be subject to Medicare price negotiations.